Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bhargava

Showing results (51-60 of 359) with videos related to

Pageof 36
Sort By:
Pharmacology, Biochemistry, and Behavior|May 1, 1980
Comparative effects of synthetic enkephalinamides and morphine on abstinence responses in morphine-dependent miceH N Bhargava
Pharmacology, Biochemistry, and Behavior|August 1, 1978
Effects of methionine-enkephalin and morphine on spontaneous locomotor activity: antagonism by naloxoneH N Bhargava
Clinical Toxicology|February 1, 1981
Mechanism of toxicity and rationale for use of the combination of pentazocine and pyribenzamine in morphine-dependent subjectsH N Bhargava
NIDA Research Monograph|January 1, 1995
Drugs that modify opioid tolerance, physical dependence, and abstinence symptoms: preclinical and clinical studiesH N Bhargava
Journal of Pharmaceutical Sciences|July 1, 1977
Improved recovery of morphine from biological tissues using siliconized glasswareH N Bhargava
Journal of the Royal College of Surgeons of Edinburgh|July 1, 1977
Spontaneous rupture of the ureterB N Bhargava
Life Sciences|March 17, 1980
The effects of thyrotropin releasing hormone and histidyl-proline diketopiperazine on delta-9-tetrahydrocannabinol-induced hypothermiaH N Bhargava
Neuropharmacology|December 1, 1983
Binding of [3H]spiroperidol to striatal membranes of rats treated chronically with morphine. Influence of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly)H N Bhargava
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1981
Inhibition of tolerance to the pharmacological effects of human beta-endorphin by prolyl-leucyl-glycinamide and cyclo(leucylglycine) in the ratH N Bhargava
Life Sciences|February 27, 1984
Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phaseH N Bhargava
Pageof 36

Showing results (51-60 of 359) with videos related to

Sort By:
Pageof 36
Pharmacology, Biochemistry, and Behavior|May 1, 1980
Comparative effects of synthetic enkephalinamides and morphine on abstinence responses in morphine-dependent miceH N Bhargava
Pharmacology, Biochemistry, and Behavior|August 1, 1978
Effects of methionine-enkephalin and morphine on spontaneous locomotor activity: antagonism by naloxoneH N Bhargava
Clinical Toxicology|February 1, 1981
Mechanism of toxicity and rationale for use of the combination of pentazocine and pyribenzamine in morphine-dependent subjectsH N Bhargava
NIDA Research Monograph|January 1, 1995
Drugs that modify opioid tolerance, physical dependence, and abstinence symptoms: preclinical and clinical studiesH N Bhargava
Journal of Pharmaceutical Sciences|July 1, 1977
Improved recovery of morphine from biological tissues using siliconized glasswareH N Bhargava
Journal of the Royal College of Surgeons of Edinburgh|July 1, 1977
Spontaneous rupture of the ureterB N Bhargava
Life Sciences|March 17, 1980
The effects of thyrotropin releasing hormone and histidyl-proline diketopiperazine on delta-9-tetrahydrocannabinol-induced hypothermiaH N Bhargava
Neuropharmacology|December 1, 1983
Binding of [3H]spiroperidol to striatal membranes of rats treated chronically with morphine. Influence of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly)H N Bhargava
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1981
Inhibition of tolerance to the pharmacological effects of human beta-endorphin by prolyl-leucyl-glycinamide and cyclo(leucylglycine) in the ratH N Bhargava
Life Sciences|February 27, 1984
Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phaseH N Bhargava
Pageof 36